Copyright Reports & Markets. All rights reserved.

Global cfDNA Testing Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of cfDNA Testing by Type
    • 1.3.1 Overview: Global cfDNA Testing Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global cfDNA Testing Consumption Value Market Share by Type in 2025
    • 1.3.3 Targeted Sequencing
    • 1.3.4 Whole Genome Sequencing
  • 1.4 Classification of cfDNA Testing by Test Type
    • 1.4.1 Overview: Global cfDNA Testing Market Size by Test Type: 2021 Versus 2025 Versus 2032
    • 1.4.2 Global cfDNA Testing Consumption Value Market Share by Test Type in 2025
    • 1.4.3 Services
    • 1.4.4 Reagent Kits
    • 1.4.5 Others
  • 1.5 Classification of cfDNA Testing Target Audiences
    • 1.5.1 Overview: Global cfDNA Testing Market Size Target Audiences: 2021 Versus 2025 Versus 2032
    • 1.5.2 Global cfDNA Testing Consumption Value Market Share Target Audiences in 2025
    • 1.5.3 LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
    • 1.5.4 DTC (Direct-to-Consumer) Services for Consumers
  • 1.6 Global cfDNA Testing Market by Application
    • 1.6.1 Overview: Global cfDNA Testing Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.6.2 Prenatal Testing
    • 1.6.3 Oncology
    • 1.6.4 Organ Transplant Monitoring
    • 1.6.5 Others
  • 1.7 Global cfDNA Testing Market Size & Forecast
  • 1.8 Global cfDNA Testing Market Size and Forecast by Region
    • 1.8.1 Global cfDNA Testing Market Size by Region: 2021 VS 2025 VS 2032
    • 1.8.2 Global cfDNA Testing Market Size by Region, (2021-2032)
    • 1.8.3 North America cfDNA Testing Market Size and Prospect (2021-2032)
    • 1.8.4 Europe cfDNA Testing Market Size and Prospect (2021-2032)
    • 1.8.5 Asia-Pacific cfDNA Testing Market Size and Prospect (2021-2032)
    • 1.8.6 South America cfDNA Testing Market Size and Prospect (2021-2032)
    • 1.8.7 Middle East & Africa cfDNA Testing Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 NIPT by LifeCodexx
    • 2.1.1 NIPT by LifeCodexx Details
    • 2.1.2 NIPT by LifeCodexx Major Business
    • 2.1.3 NIPT by LifeCodexx cfDNA Testing Product and Solutions
    • 2.1.4 NIPT by LifeCodexx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 NIPT by LifeCodexx Recent Developments and Future Plans
  • 2.2 Genodive Pharma
    • 2.2.1 Genodive Pharma Details
    • 2.2.2 Genodive Pharma Major Business
    • 2.2.3 Genodive Pharma cfDNA Testing Product and Solutions
    • 2.2.4 Genodive Pharma cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Genodive Pharma Recent Developments and Future Plans
  • 2.3 Riken Genesis
    • 2.3.1 Riken Genesis Details
    • 2.3.2 Riken Genesis Major Business
    • 2.3.3 Riken Genesis cfDNA Testing Product and Solutions
    • 2.3.4 Riken Genesis cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Riken Genesis Recent Developments and Future Plans
  • 2.4 GC Genome
    • 2.4.1 GC Genome Details
    • 2.4.2 GC Genome Major Business
    • 2.4.3 GC Genome cfDNA Testing Product and Solutions
    • 2.4.4 GC Genome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 GC Genome Recent Developments and Future Plans
  • 2.5 EDGC
    • 2.5.1 EDGC Details
    • 2.5.2 EDGC Major Business
    • 2.5.3 EDGC cfDNA Testing Product and Solutions
    • 2.5.4 EDGC cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 EDGC Recent Developments and Future Plans
  • 2.6 Natera
    • 2.6.1 Natera Details
    • 2.6.2 Natera Major Business
    • 2.6.3 Natera cfDNA Testing Product and Solutions
    • 2.6.4 Natera cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Natera Recent Developments and Future Plans
  • 2.7 CareDx
    • 2.7.1 CareDx Details
    • 2.7.2 CareDx Major Business
    • 2.7.3 CareDx cfDNA Testing Product and Solutions
    • 2.7.4 CareDx cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 CareDx Recent Developments and Future Plans
  • 2.8 BillionToOne, Inc.
    • 2.8.1 BillionToOne, Inc. Details
    • 2.8.2 BillionToOne, Inc. Major Business
    • 2.8.3 BillionToOne, Inc. cfDNA Testing Product and Solutions
    • 2.8.4 BillionToOne, Inc. cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 BillionToOne, Inc. Recent Developments and Future Plans
  • 2.9 ARUP Laboratories
    • 2.9.1 ARUP Laboratories Details
    • 2.9.2 ARUP Laboratories Major Business
    • 2.9.3 ARUP Laboratories cfDNA Testing Product and Solutions
    • 2.9.4 ARUP Laboratories cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 ARUP Laboratories Recent Developments and Future Plans
  • 2.10 Guardant Health
    • 2.10.1 Guardant Health Details
    • 2.10.2 Guardant Health Major Business
    • 2.10.3 Guardant Health cfDNA Testing Product and Solutions
    • 2.10.4 Guardant Health cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Guardant Health Recent Developments and Future Plans
  • 2.11 GRAIL
    • 2.11.1 GRAIL Details
    • 2.11.2 GRAIL Major Business
    • 2.11.3 GRAIL cfDNA Testing Product and Solutions
    • 2.11.4 GRAIL cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 GRAIL Recent Developments and Future Plans
  • 2.12 Foundation Medicine
    • 2.12.1 Foundation Medicine Details
    • 2.12.2 Foundation Medicine Major Business
    • 2.12.3 Foundation Medicine cfDNA Testing Product and Solutions
    • 2.12.4 Foundation Medicine cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Foundation Medicine Recent Developments and Future Plans
  • 2.13 MedGenome
    • 2.13.1 MedGenome Details
    • 2.13.2 MedGenome Major Business
    • 2.13.3 MedGenome cfDNA Testing Product and Solutions
    • 2.13.4 MedGenome cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 MedGenome Recent Developments and Future Plans
  • 2.14 Lucence
    • 2.14.1 Lucence Details
    • 2.14.2 Lucence Major Business
    • 2.14.3 Lucence cfDNA Testing Product and Solutions
    • 2.14.4 Lucence cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Lucence Recent Developments and Future Plans
  • 2.15 BGI Genomics
    • 2.15.1 BGI Genomics Details
    • 2.15.2 BGI Genomics Major Business
    • 2.15.3 BGI Genomics cfDNA Testing Product and Solutions
    • 2.15.4 BGI Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 BGI Genomics Recent Developments and Future Plans
  • 2.16 Berry Genomics
    • 2.16.1 Berry Genomics Details
    • 2.16.2 Berry Genomics Major Business
    • 2.16.3 Berry Genomics cfDNA Testing Product and Solutions
    • 2.16.4 Berry Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Berry Genomics Recent Developments and Future Plans
  • 2.17 Burning Rock
    • 2.17.1 Burning Rock Details
    • 2.17.2 Burning Rock Major Business
    • 2.17.3 Burning Rock cfDNA Testing Product and Solutions
    • 2.17.4 Burning Rock cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Burning Rock Recent Developments and Future Plans
  • 2.18 ACT Genomics
    • 2.18.1 ACT Genomics Details
    • 2.18.2 ACT Genomics Major Business
    • 2.18.3 ACT Genomics cfDNA Testing Product and Solutions
    • 2.18.4 ACT Genomics cfDNA Testing Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 ACT Genomics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global cfDNA Testing Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of cfDNA Testing by Company Revenue
    • 3.2.2 Top 3 cfDNA Testing Players Market Share in 2025
    • 3.2.3 Top 6 cfDNA Testing Players Market Share in 2025
  • 3.3 cfDNA Testing Market: Overall Company Footprint Analysis
    • 3.3.1 cfDNA Testing Market: Region Footprint
    • 3.3.2 cfDNA Testing Market: Company Product Type Footprint
    • 3.3.3 cfDNA Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global cfDNA Testing Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global cfDNA Testing Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global cfDNA Testing Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global cfDNA Testing Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America cfDNA Testing Consumption Value by Type (2021-2032)
  • 6.2 North America cfDNA Testing Market Size by Application (2021-2032)
  • 6.3 North America cfDNA Testing Market Size by Country
    • 6.3.1 North America cfDNA Testing Consumption Value by Country (2021-2032)
    • 6.3.2 United States cfDNA Testing Market Size and Forecast (2021-2032)
    • 6.3.3 Canada cfDNA Testing Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico cfDNA Testing Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe cfDNA Testing Consumption Value by Type (2021-2032)
  • 7.2 Europe cfDNA Testing Consumption Value by Application (2021-2032)
  • 7.3 Europe cfDNA Testing Market Size by Country
    • 7.3.1 Europe cfDNA Testing Consumption Value by Country (2021-2032)
    • 7.3.2 Germany cfDNA Testing Market Size and Forecast (2021-2032)
    • 7.3.3 France cfDNA Testing Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom cfDNA Testing Market Size and Forecast (2021-2032)
    • 7.3.5 Russia cfDNA Testing Market Size and Forecast (2021-2032)
    • 7.3.6 Italy cfDNA Testing Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific cfDNA Testing Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific cfDNA Testing Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific cfDNA Testing Market Size by Region
    • 8.3.1 Asia-Pacific cfDNA Testing Consumption Value by Region (2021-2032)
    • 8.3.2 China cfDNA Testing Market Size and Forecast (2021-2032)
    • 8.3.3 Japan cfDNA Testing Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea cfDNA Testing Market Size and Forecast (2021-2032)
    • 8.3.5 India cfDNA Testing Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia cfDNA Testing Market Size and Forecast (2021-2032)
    • 8.3.7 Australia cfDNA Testing Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America cfDNA Testing Consumption Value by Type (2021-2032)
  • 9.2 South America cfDNA Testing Consumption Value by Application (2021-2032)
  • 9.3 South America cfDNA Testing Market Size by Country
    • 9.3.1 South America cfDNA Testing Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil cfDNA Testing Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina cfDNA Testing Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa cfDNA Testing Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa cfDNA Testing Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa cfDNA Testing Market Size by Country
    • 10.3.1 Middle East & Africa cfDNA Testing Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey cfDNA Testing Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia cfDNA Testing Market Size and Forecast (2021-2032)
    • 10.3.4 UAE cfDNA Testing Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 cfDNA Testing Market Drivers
  • 11.2 cfDNA Testing Market Restraints
  • 11.3 cfDNA Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 cfDNA Testing Industry Chain
  • 12.2 cfDNA Testing Upstream Analysis
  • 12.3 cfDNA Testing Midstream Analysis
  • 12.4 cfDNA Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global cfDNA Testing market size was valued at US$ 10405 million in 2025 and is forecast to a readjusted size of US$ 19925 million by 2032 with a CAGR of 9.9% during review period.
    cfDNA testing is a precision medicine service that involves collecting human bodily fluid samples (such as blood or urine) to extract extracellular DNA fragments. By employing molecular detection technologies—including next-generation sequencing (NGS), droplet digital PCR (ddPCR), standard PCR, and methylation analysis—these fragments are analyzed for gene mutations, chromosomal abnormalities, methylation patterns, and genomic information to facilitate disease screening, diagnosis, treatment monitoring, and prognostic assessment. cfDNA originates primarily from DNA released during normal cell apoptosis and from DNA shed by specialized tissues such as tumor cells and placental cells; tumor-derived cfDNA (ctDNA) is utilized for cancer liquid biopsies, while non-invasive prenatal testing (NIPT) screens for chromosomal abnormalities using fetal-derived cfDNA found in maternal blood. Compared to traditional tissue biopsies, cfDNA testing offers advantages such as being minimally invasive, allowing for repeated sampling, and providing a real-time reflection of disease status, making it a key technological direction in liquid biopsy and precision medicine.
    Driven by the rapid advancement of global precision medicine, liquid biopsy, and genetic testing technologies, the cfDNA testing market holds significant growth potential. In oncology, the rising demand for early cancer screening, monitoring of minimal residual disease (MRD), and companion diagnostics for targeted therapies has established ctDNA testing as a vital tool for precision diagnosis and treatment. In the field of obstetrics and gynecology, NIPT has emerged as one of the most commercially mature applications of cfDNA testing. Furthermore, new applications—such as organ transplant monitoring, genetic disease screening, and infectious disease detection—are continuously expanding. Looking ahead, as sequencing costs decrease, AI-assisted analysis capabilities improve, and testing standards are refined, cfDNA testing will evolve from single-disease detection toward multi-cancer early screening, dynamic health monitoring, and personalized treatment. The global cfDNA testing market is projected to maintain a compound annual growth rate (CAGR) of over 10%, positioning it as a rapidly growing segment within the molecular diagnostics industry.
    Report Scope
    This report is a detailed and comprehensive analysis for global cfDNA Testing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global cfDNA Testing market size and forecasts, in consumption value ($ Million), 2021-2032
    Global cfDNA Testing market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global cfDNA Testing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global cfDNA Testing market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for cfDNA Testing
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global cfDNA Testing market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include NIPT by LifeCodexx, Genodive Pharma, Riken Genesis, GC Genome, EDGC, Natera, CareDx, BillionToOne, Inc., ARUP Laboratories, Guardant Health, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    cfDNA Testing market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Targeted Sequencing
    Whole Genome Sequencing
    Market segment by Test Type
    Services
    Reagent Kits
    Others
    Market segment Target Audiences
    LDT (Laboratory-Driven Treatment) Services for Healthcare Institutions
    DTC (Direct-to-Consumer) Services for Consumers
    Market segment by Application
    Prenatal Testing
    Oncology
    Organ Transplant Monitoring
    Others
    Market segment by players, this report covers
    NIPT by LifeCodexx
    Genodive Pharma
    Riken Genesis
    GC Genome
    EDGC
    Natera
    CareDx
    BillionToOne, Inc.
    ARUP Laboratories
    Guardant Health
    GRAIL
    Foundation Medicine
    MedGenome
    Lucence
    BGI Genomics
    Berry Genomics
    Burning Rock
    ACT Genomics
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    Chapter Outline
    Chapter 1, to describe cfDNA Testing product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of cfDNA Testing, with revenue, gross margin, and global market share of cfDNA Testing from 2021 to 2026.
    Chapter 3, the cfDNA Testing competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and cfDNA Testing market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of cfDNA Testing.
    Chapter 13, to describe cfDNA Testing research findings and conclusion.

    Buy now